Total weight loss at 48-68 weeks on the combination is difficult to predict without clinical trial data, but based on individual compound data (retatrutide at 24-28.7% and the additive benefit seen with CagriSema), a reasonable estimate for the combination is 25-35% total body weight reduction in high responders
In this article, Ill explore the origins of these concerns, examine why they may not apply to humans, and discuss what the data shows about thyroid cancer risks in people using GLP-1 medications
Because the active ingredient is the same, they share many potential side effects
Under proper supervision, a medical professional can adjust your dose, stop treatment, or give appropriate medical intervention based on your individual needs to avoid side effects
Looking Ahead While the data are promising, the existing body of evidence is still limited by small sample sizes and observational study designs
If youve shaken it hard, its unfortunately best to discard it to ensure the integrity of your study